GlassScriptPhysician profile
Orlando Rodriguez
NPI 1043392335
$1,350.39
in general payments reported to CMS, 2019-2025
18 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $108 · 2021: $182 · 2022: $199 · 2023: $282 · 2024: $199 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $300.26 | 2019-2025 | Vaxneuvance, Gardasil 9, Janumet |
| Novo Nordisk INC | $211.16 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $150.08 | 2019-2023 | Shingrix, Arexvy, Pediarix |
| Pfizer INC. | $135.70 | 2022-2025 | |
| Amgen INC. | $120.19 | 2019-2024 | Otezla, Repatha |
| Abbvie INC. | $108.94 | 2019-2025 | Ubrelvy |
| Dynavax Technologies Corporation | $67.10 | 2022-2023 | Heplisav-B |
| Coopersurgical, INC. | $45.49 | 2020 | |
| Hologic Sales and Service, LLC | $33.25 | 2019-2025 | Aptima |
| Lilly USA, LLC | $29.00 | 2019-2022 | |
| Organon LLC | $25.15 | 2021-2024 | |
| Abbott Laboratories | $23.10 | 2023 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $19.30 | 2024 | Voquezna |
| Exact Sciences Corporation | $19.04 | 2023 | Cologuard Collection Kit |
| Seqirus USA INC | $18.42 | 2025 | Flucelvax, Fluad |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $15.87 | 2025 | Apretude |
| Medtronic, INC. | $15.09 | 2022 | |
| Allergan, INC. | $13.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Orlando Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.